Prediction of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization: A Real-World Study Based on Non-Contrast Computed Tomography Radiomics and General Image Features

References

• Zhu XD, Sun HC. Emerging agents and regimens for hepatocellular carcinoma. J Hematol Oncol. 2019;12(1):110. doi:10.1186/s13045-019-0794-6
   PubMed Web of Science ®Google Scholar
• Sacco R, Tapete G, Simonetti N, et al. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2017;4:105–110. doi:10.2147/JHC.S103661
   Web of Science ®Google Scholar
• Chen LT, Martinelli E, Cheng AL, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol. 2020;31(3):334–351. doi:10.1016/j.annonc.2019.12.001
   PubMed Web of Science ®Google Scholar
• Li XH, Wei L. [The comparison among the guidelines for the diagnosis and treatment of hepatocellular carcinoma in China, AASLD and EASL]. Zhonghua Gan Zang Bing Za Zhi. 2019;27(3):236–240. (Chinese). doi:10.3760/cma.j.issn.1007-3418.2019.03.015
   Google Scholar
• Rimola J. Heterogeneity of hepatocellular carcinoma on imaging. Semin Liver Dis. 2020;40(1):61–69. doi:10.1055/s-0039-1693512
   Web of Science ®Google Scholar
• Xu LX, He MH, Dai ZH, et al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;30(6):990–997. doi:10.1093/annonc/mdz103
   PubMed Web of Science ®Google Scholar
• Department of Medical Administration NH, Health Commission of the People’s Republic of C. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2020;28(2):112–128. (Chinese). doi:10.3760/cma.j.issn.1007-3418.2020.02.004
   PubMedGoogle Scholar
• Pesapane F, Nezami N, Patella F, Geschwind JF. New concepts in embolotherapy of HCC. Med Oncol. 2017;34(4):58. doi:10.1007/s12032-017-0917-2
   PubMed Web of Science ®Google Scholar
• Kadalayil L, Benini R, Pallan L, et al. A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol. 2013;24(10):2565–2570. doi:10.1093/annonc/mdt247
   PubMed Web of Science ®Google Scholar
• Wang Q, Xia D, Bai W, et al. Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study. J Hepatol. 2019;70(5):893–903. doi:10.1016/j.jhep.2019.01.013
   PubMed Web of Science ®Google Scholar
• Han G, Berhane S, Toyoda H, et al. Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response-based approach. Hepatology. 2020;72(1):198–212. doi:10.1002/hep.31022
   PubMed Web of Science ®Google Scholar
• Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762. doi:10.1038/nrclinonc.2017.141
   PubMed Web of Science ®Google Scholar
• Fave X, Zhang L, Yang J, et al. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep. 2017;7(1):588. doi:10.1038/s41598-017-00665-z
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23(23):7253–7262. doi:10.1158/1078-0432.CCR-17-1038
   PubMed Web of Science ®Google Scholar
• Liu D, Liu F, Xie X, et al. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol. 2020;30(4):2365–2376. doi:10.1007/s00330-019-06553-6
   PubMed Web of Science ®Google Scholar
• Sun Y, Bai H, Xia W, et al. Predicting the outcome of transcatheter arterial embolization therapy for unresectable hepatocellular carcinoma based on radiomics of preoperative multiparameter MRI. J Magn Reson Imaging. 2020;52(4):1083–1090. doi:10.1002/jmri.27143
   Web of Science ®Google Scholar
• Weng W, Lu XL, Zhang QQ, et al. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology]. Zhonghua Yi Xue Za Zhi. 2020;100(11):828–832. (Chinese). doi:10.3760/cma.j.cn112137-20190705-01502
   Google Scholar
• Peng J, Kang S, Ning Z, et al. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. Eur Radiol. 2020;30(1):413–424. doi:10.1007/s00330-019-06318-1
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60. doi:10.1055/s-0030-1247132
   PubMed Web of Science ®Google Scholar
• Szczypinski PM, Strzelecki M, Materka A, Klepaczko A. MaZda--a software package for image texture analysis. Comput Methods Programs Biomed. 2009;94(1):66–76. doi:10.1016/j.cmpb.2008.08.005
   Web of Science ®Google Scholar
• Wang R, Su Y, Mao C, Li S, You M, Xiang S. Laser lithotripsy for proximal ureteral calculi in adults: can 3D CT texture analysis help predict treatment success? Eur Radiol. 2020.
   Web of Science ®Google Scholar
• Cavallo AU, Troisi J, Forcina M, et al. Texture analysis in the evaluation of Covid-19 pneumonia in chest X-Ray images: a Proof of Concept Study. Curr Med Imaging. 2021;17. doi:10.2174/1573405617999210112195450
   Web of Science ®Google Scholar
• de Baere T, Arai Y, Lencioni R, et al. Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion. Cardiovasc Intervent Radiol. 2016;39(3):334–343. doi:10.1007/s00270-015-1208-y
   PubMed Web of Science ®Google Scholar
• Golfieri R, Bargellini I, Spreafico C, Trevisani F. Patients with Barcelona clinic liver cancer stages B and C hepatocellular carcinoma: time for a subclassification. Liver Cancer. 2019;8(2):78–91. doi:10.1159/000489791
   PubMed Web of Science ®Google Scholar
• Jeong SO, Kim EB, Jeong SW, et al. Predictive factors for complete response and recurrence after transarterial chemoembolization in hepatocellular carcinoma. Gut Liver. 2017;11(3):409–416. doi:10.5009/gnl16001
   PubMed Web of Science ®Google Scholar
• Wu B, Zhou J, Ling G, Zhu D, Long Q. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study. World J Surg Oncol. 2018;16(1):69. doi:10.1186/s12957-018-1368-8
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu AH, Wang W, Wu YH, Sun QL, Shu C. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation. BMC Cancer. 2019;19(1):1041. doi:10.1186/s12885-019-6265-1
   Web of Science ®Google Scholar
• Song W, Yu X, Guo D, et al. MRI-based radiomics: associations with the recurrence-free survival of patients with hepatocellular carcinoma treated with conventional transcatheter arterial chemoembolization. J Magn Reson Imaging. 2020;52(2):461–473. doi:10.1002/jmri.26977
   Web of Science ®Google Scholar
• Kim J, Choi SJ, Lee SH, Lee HY, Park H. Predicting survival using pretreatment CT for patients with hepatocellular carcinoma treated with transarterial chemoembolization: comparison of models using radiomics. AJR Am J Roentgenol. 2018;211(5):1026–1034. doi:10.2214/AJR.18.19507
   PubMed Web of Science ®Google Scholar
• Meng XP, Wang YC, Ju S, et al. Radiomics analysis on multiphase contrast-enhanced CT: a survival prediction tool in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Front Oncol. 2020;10:1196. doi:10.3389/fonc.2020.01196
   PubMed Web of Science ®Google Scholar
• Casadei-Gardini A, Giulia O, Francesco C, Giorgio E. Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Rev Anticancer Ther. 2020;20(1):63–74. doi:10.1080/14737140.2020.1712198
   PubMed Web of Science ®Google Scholar